Clinical Trial Update: Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle (Rapamune) [NA]

View source ↗

Summary

A University of Nottingham-led clinical trial is evaluating the effects of mTOR inhibition with sirolimus (Rapamune) on age-related muscle loss (sarcopenia) and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Atrophy
• Sarcopenia

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: University of Nottingham | Conditions: Muscle Atrophy, Age-Related Sarcopenia | NA | Status: RECRUITING